Sol-Gel Technologies (SLGL) Asset Utilization Ratio (2018 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Asset Utilization Ratio of 0.42 for Q1 2026, up 8.49% year-over-year from 0.38 in Q1 2025, and down 30.55% quarter-over-quarter from 0.6 in Q4 2025.
Analysis
Sol-Gel Technologies (SLGL) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Asset Utilization Ratio for 9 consecutive years, with 0.42 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 8.49% year-over-year to 0.42; the TTM figure through Mar 2026 stood at 0.42 (up 8.49% YoY), while the FY2025 annual figure was 0.59, up 107.31% from the prior year.
- Asset Utilization Ratio declined to 0.42 in Q1 2026 per SLGL's latest filing, from 0.6 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 61.36 in Q4 2022 and bottomed at 0.02 in Q3 2023.
- Historically, Asset Utilization Ratio has averaged 14.97 across 5 years, with a median of 0.42 in 2026.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 56136.96% — and 2023, when it slumped 99.96%.
- Sol-Gel Technologies' Asset Utilization Ratio stood at 61.36 in 2022, then plunged by 99.95% to 0.03 in 2023, then surged by 926.91% to 0.29 in 2024, then surged by 105.67% to 0.6 in 2025, then slumped by 30.55% to 0.42 in 2026.
- Business Quant data shows SLGL's Asset Utilization Ratio at 0.42 in Q1 2026, 0.6 in Q4 2025, and 0.51 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Sol-Gel Technologies | 194.01 Mn | 146.08 Mn | - | 0.03 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.72 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.29 |
| Sep 30, 2024 | 0.28 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.46 |
| Mar 31, 2022 | 0.37 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.10 |